- Home
- ICCT vs MIRA Comparison
ICCT vs MIRA Comparison
Compare ICCT & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- MIRA
- Stock Information
- Founded
- ICCT 1992
- MIRA 2020
- Country
- ICCT United States
- MIRA United States
- Employees
- ICCT N/A
- MIRA N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- ICCT Technology
- MIRA Health Care
- Exchange
- ICCT Nasdaq
- MIRA Nasdaq
- Market Cap
- ICCT 5.2M
- MIRA 17.1M
- IPO Year
- ICCT N/A
- MIRA 2023
- Fundamental
- Price
- ICCT $0.28
- MIRA $1.05
- Analyst Decision
- ICCT
- MIRA Strong Buy
- Analyst Count
- ICCT 0
- MIRA 2
- Target Price
- ICCT N/A
- MIRA $14.00
- AVG Volume (30 Days)
- ICCT 5.8M
- MIRA 538.5K
- Earning Date
- ICCT 11-18-2024
- MIRA 11-11-2024
- Dividend Yield
- ICCT N/A
- MIRA N/A
- EPS Growth
- ICCT N/A
- MIRA N/A
- EPS
- ICCT N/A
- MIRA N/A
- Revenue
- ICCT $10,266,331.00
- MIRA N/A
- Revenue This Year
- ICCT N/A
- MIRA N/A
- Revenue Next Year
- ICCT N/A
- MIRA N/A
- P/E Ratio
- ICCT N/A
- MIRA N/A
- Revenue Growth
- ICCT 34.56
- MIRA N/A
- 52 Week Low
- ICCT $0.25
- MIRA $0.51
- 52 Week High
- ICCT $3.20
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- ICCT 35.30
- MIRA 38.49
- Support Level
- ICCT $0.34
- MIRA $1.05
- Resistance Level
- ICCT $0.37
- MIRA $1.12
- Average True Range (ATR)
- ICCT 0.07
- MIRA 0.07
- MACD
- ICCT -0.00
- MIRA 0.02
- Stochastic Oscillator
- ICCT 5.67
- MIRA 12.00
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.